News and Events

Symposia, Presentations & Special Events

Time (CDT)

Location

Presenter/Contributing Author

Event / Presentation Title

Type: Track & Topic [Identifier]

7:30 a.m. - 10:30 a.m.

VU Rooftop:

133 E. Cermak, Chicago, IL 60616

W!LD's "Hot Breakfast, Hot Topics" at ADA in Chicago - Honoring Linda DiMeglio, MPH, MD

(RSVP to wild@closeconcerns.com)

12:45 p.m. - 1:45 p.m.

W185 A-D

Linda A. DiMeglio, MPH, MD

Chair: Diabetes in Children—Pediatric Type 1 Diabetes—Decoding the Disease and Transforming Care

Oral Presentation: Clinical Diabetes/Therapeutics & Pediatrics

12:45 p.m. - 1:45 p.m.

W194 AB

Hyun Cheol Roh, PhD

Chair: Molecular and Cellular Mechanisms Driving Muscle Atrophy and Dysfunction

Oral Presentation: Obesity/Integrated Physiology & Metabolism/In Vivo (Animals)

1:30 p.m. - 1:45 p.m.

W192 A-C

Matthew C. Austin, BS

Decoding Type 1 Diabetes—Lessons from Trials and Deep Data Dives

Dysfunctional β-Cell Autophagy Stimulates Lysosomal Exocytosis, Promoting Alterations in the Secretome and Antigen Presentation Pathways

Oral Presentation: Immunology/Beta-Cell Replacement & Immunology [Board No. 32]

2:45 p.m. - 3:00 p.m.

W190 A

Irene Amalaraj, BA

Apoptosis (Living, Dying, and Surviving in the Pancreatic Islet)

STAT-Dependent β-Cell Extracellular Vesicle (EV) Programmed Death-Ligand 1 (PD-L1) Shuttling Abrogates CD4+ T Cell Activation in Type 1 Diabetes (T1D)

Oral Presentation: Islet Biology/Insulin Secretion [Board No. 80]

3:15 p.m. - 3:30 p.m.

W190 A

Christopher J. Contreras, PhD

Apoptosis (Living, Dying, and Surviving in the Pancreatic Islet)

RIPK1 Kinase Activity Regulates Cytokine-Induced β-Cell Cytotoxicity

Oral Presentation: Islet Biology/Insulin Secretion

[Board No. 82]

3:45 p.m. - 5:15 p.m.

W183 A

Christina M. Scifres, MD

Chair: Controversies in Peripartum Management of Diabetes

Symposium: Clinical Diabetes/Therapeutics & Pregnancy

4:25 p.m. - 4:45 p.m.

W186 A-C

Ricardo Melo Ferreira, PhD

Opening a Door to Precision Medicine—Lessons from Human Kidney Tissue in Diabetes

Endothelial Cell Fates in Diabetic Kidney Disease—Lessons from the Kidney Precision Medicine Project

Symposium: Acute and Chronic Complications & Diabetic Kidney Disease

Symposia, Presentations & Special Events

Time (CDT)

Location

Presenter/Contributing Author

Event / Presentation Title

Type: Track & Topic [Identifier]

8:00 a.m. - 9:30 a.m.

W186 A-C

Armando Peña, PhD

Type 2 Diabetes—From Biology to Behavior, Is It All In The Family?

Interrupting the Intergenerational Cycle of Type 2 Diabetes

Symposium: Epidemiology/Genetics & Epidemiology

8:00 a.m. - 9:30 a.m.

W190 A

Hyun Cheol Roh, PhD

Chair: New Technologies to Address Old Questions in Molecular Metabolism

Symposium: Insulin Action/Molecular Metabolism

12:30 p.m. - 1:30 p.m.

Product Theater 2

Viral N. Shah, MD

Invited Speaker: Life with diabetes just got easier

Product Theaters

1:30 p.m. - 3:00 p.m.

W180

Christina M. Scifres, MD

Chair: New Approaches to Detect and Monitor Diabetes in Pregnancy

Oral Presentation: Clinical Diabetes/Therapeutics & Pregnancy

2:45 p.m. - 3:00 p.m.

W187 A-C

Eslam Montaser, PhD

Evaluating the Impact of Type 1 Diabetes Interventions on A1C and GMI across Glycemic Categories

Oral Presentation: Clinical Diabetes/Therapeutics & New Technology

[Board No. 170]

3:15 p.m. - 3:30 p.m.

W183 BC

Carla Miller, PhD, RD

GLP-1RAs—Miracle Drug or Behavioral Health Minefield?

From Peptides to Plates—Understanding Nutrition Concerns with GLP-1RAs

Ask the Expert: Behavioral Medicine/Clinical Nutrition/Education and Exercise & Psychosocial/Behavioral Medicine

4:00 p.m. - 4:15 p.m.

W183 A

Lisa Staten, PhD

Panelist: Cross-Sectoral Platforms—Transforming Diabetes Prevention for All

The Diabetes Impact Project—An Example of a Successful Multisector Partnership to Reduce Diabetes Burden in Indianapolis Communities

Panel Discussion: Epidemiology/Genetics & Epidemiology

4:30 p.m. - 4:50 p.m.

W184 A-D

Tamara S. Hannon, MD

Everything You Want to Know about the Latest Advances in Pediatric Type 2 Diabetes

Single and Dual Incretin Analogs for Treatment of Pediatric Type 2 Diabetes—Where Do We Stand Now, and What Gaps Are Yet to Be Filled?

Symposium: Clinical Diabetes/Therapeutics & Pediatrics

Posters

Presenter

Title

Identifier

From 12:30 p.m. to 1:30 p.m. CDT in the Poster Hall and Exhibit Hall ePoster Theater B

Helen N. Chen, PhD

Examining Therapeutic Inertia in Adults with Type 2 Diabetes Mellitus—Time-to-Event Analysis

Board No. 1438

Helen N. Chen, PhD

Characteristics of Insulin Prescriptions and Type 2 Diabetes Glycemic Control in Adults

Board No. 1439

Noha El Yaman, MD

Does Patient Activation Correlate with Lifestyle Change Program Study Completion in Patients with a History of Gestational Diabetes Mellitus?

Board No. 609

Heba M. Ismail, MB, BCh, PhD

Risk Profiles and Characteristics of Relatives of People with Type 1 Diabetes (T1D) with Single Autoantibody (SAB) Reversion

Board No. 1523

Heba M. Ismail, MB, BCh, PhD

The Progression of 2-Hour Glucose (2hGLU) to Impaired Glucose Tolerance (IGT) and Its Reversion in Antibody-Positive (Ab+) Individuals

Board No. 1524

David Jomar Sanchez Rodriguez, BS

Small Molecule Allosteric Activators of SERCA Improve β-Cell Viability and Calcium Homeostasis

Board No. 717

Emily K. Sims, MD

A Novel Approach for Assessing Treatment Failure vs. Success at Fixed Time Intervals in T1D Prevention Trials

Board No. 715

Mark David Woollam, PhD

Noninvasive Detection of Hyperglycemic Events in Persons with Diabetes through Development of a Breath-Based Sensor Array

Board No. 1023

Jerry Xu, PhD

Neutral Sphingomyelinase 2 (nSMase2) Regulates Insulin Synthesis, Secretion, and Glucose Sensing

Board No. 1576

Evelyn Claire Stepaniak, BS

The Relationship between Dietary Intake and Glucose Levels in a Pilot Randomized Clinical Trial of Intensive Glycemic Targets in Gestational Diabetes

ePoster Theater:

Board No. 1237

Symposia, Presentations & Special Events

Time (CDT)

Location

Presenter/Contributing Author

Event / Presentation Title

Type: Track & Topic [Identifier]

11:30 a.m. - 12:30 p.m.

W187 A-C

Heba M. Ismail, MB, BCh, PhD

Chair: Discussion on Diabetes in Youth—D-Tech and DEB—The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using Diabetes Devices

Professional Interest Group: Clinical Diabetes/Therapeutics & Pediatrics

11:36 a.m. - 11:51 a.m.

W185 A-D

Tamara S. Hannon, MD

Discussion on Public Health and Epidemiology—Diabetes Prevention Across Ages and Settings

Preventing Diabetes in Children

Professional Interest Group: Epidemiology/Genetics & Epidemiology

11:50 a.m. - 12:10 p.m.

W183 BC

Jamie L. Felton, MD

Discussion on Immunology and Beta-Cell Replacement—Unraveling the Immunological Puzzle of Type 1 Diabetes—The Converging Roles of T Cells, B Cells, and Innate Immunity

Beta-Cell Antigen Reactive B Cells—Diagnostic Tools and Drivers of Autoimmunity

Professional Interest Group: Immunology/Beta-Cell Replacement & Immunology

12:30 p.m. – 1:30 p.m.

Shop ADA Bookstore:

Central Concourse (Level 3)

Book Launch & Signing Event – “Clinical Decision Algorithms in Diabetes: A Practical Pocket Reference for Diagnosis, Classification, and Management of Diabetes and its Complications” by Viral N. Shah, MD, and Halis Kaan Akturk, MD

4:30 p.m. - 6:00 p.m.

W185 A-D

Viral N. Shah, MD

Use of GLP-1RAs and SGLT2i with Automated Insulin Delivery Systems

AID and GLP-1—Adjusting Automated Insulin Delivery Systems to Optimize Time in Range

Ask the Expert: Clinical Diabetes/Therapeutics & New Technology

Posters

Presenter

Title

Identifier

From 12:30 p.m. to 1:30 p.m. CDT in the Poster Hall

Taylor Bynarowicz, MD

Early Pregnancy Body Roundness Index and Development of Gestational Diabetes and Hypertensive Disorders of Pregnancy

Board No. 1261

Richard DiMarchi, PhD

MBX 1416, a Selective GLP-1 Antagonist, Elevates and Sustains Blood Glucose in Rats without Change in Body Weight

Board No. 845

Eli H. Hagedorn, MS, BS

Effects of Temperature and Preservative Selection on C-Peptide Degradation in Randomly Voided Urine

Board No. 1106

Hongxia Ren, PhD

Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis Responsiveness in Diet-Induced Obesity Model

Board No. 2181

Evelyn Claire Stepaniak, BS

The Relationship between Dietary Intake and Glucose Levels in a Pilot Randomized Clinical Trial of Intensive Glycemic Targets in Gestational Diabetes

Board No. 1237

Xun Sun, PhD

G Protein-Coupled Receptor 17 (GPR17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models

Board No. 2149

Symposia, Presentations & Special Events

Time (CDT)

Location

Presenter/Contributing Author

Event / Presentation Title

Type: Track & Topic [Identifier]

3:40 p.m. - 3:55 p.m.

W196 BC

Viral N. Shah, MD

ADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) Trial Outcomes

Results (Primary and Key Secondary Outcomes)

Symposium: Clinical Diabetes/Therapeutics

Posters

Presenter

Title

Identifier

From 12:30 p.m. to 1:30 p.m. CDT in the Poster Hall

Renato C.S. Branco, PhD

RIPK1 Mediates Nucleic Acid Sensor Expression and IFNγ+dsRNA-Induced β-Cell Death

Board No. 1795

Andre G. De Oliveira, PhD

HIF1A as a Possible miR-21 Transcriptional Regulator in Proinflammatory Islet Stress

Board No. 1848

Jonathan D. Douros, PhD

A GLP-1 Analogue Optimized for cAMP-Biased Signaling Improves Weight Loss in Obese Mice

Board No. 1684

Jonathan D. Douros, PhD

Ectopic Hepatic GLP-1R Agonism Enhances the Weight Loss Efficacy of GLP-1 Analogues

Board No. 1685

Noha El Yaman, MD

Evolving Trends in GLP-1 Receptor Agonist Prescriptions for Pediatric Type 2 Diabetes—A Retrospective Analysis (2019–2024)

Board No. 1158

Maryalice Hartley, BS

SERCA2 Regulates the Lipidome and Insulin Secretion in Pancreatic β-Cells

Board No. 1832

Heba M. Ismail, MB, BCh, PhD

Genetic Ancestry and Progression through Type 1 Diabetes (T1D) Stages

Board No. 1525

Tatsuyoshi Kono, PhD

STIM1 Deficiency Impairs Glucose Regulation by Altering Insulin Granules, Mitochondria, and Endoplasmic Reticulum Ultrastructure in Beta Cells

Board No. 1828

Madeline McLaughlin, BS

STIM1 Interacts with GPER Signaling to Maintain β-Cell Identity in Female Mice

Board No. 1808

Madeline McLaughlin, BS

Ultra-high Resolution Imaging Enables Quantification of β-Cell ER

Board No. 1809

Hyun Cheol Roh, PhD

Serum Response Factor (SRF) Drives Actin Cytoskeletal Remodeling in Adipocytes to Support Hypertrophic Growth and Lipid Storage during Obesity

Board No. 1712

Cameron Rostron, BS

Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA2) Dysfunction Contributes to β-Cell Stress and the Development of Chemically Induced Type 1 Diabetes

Board No. 1826

Jerry Xu, PhD

Beta-Cell Extracellular Vesicles—Transfer to and Impact on Neighboring Cells

Board No. 1810